Uterine Fibroid Treatment Device Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Medtronic plc (NYSE: MDT), Stryker Corporation (NYSE: SYK), Hologic Inc. (NASDAQ: HOLX)

Registering a CAGR of 9.6% over the forecast period, the market value of Uterine Fibroid Treatment Device is expected to reach US$ 840.90 million in the year 2027.

Uterine Fibroid Treatment Device Market Overview

Medical devices used to treat uterine fibroid in women are known as uterine fibroid treatment devices. Uterine fibroids are small, harmless tumors that develop in the uterine wall. These are not cancerous and do not spread. Uterine fibroids cause symptoms such as frequent urination, pelvic pain, constipation, and menstrual bleeding. Because of its minimally invasive nature, uterine fibroid embolization (UFE) has seen widespread use in recent years. Fluoroscopy, a real-time x-ray technique, is used to guide the delivery of embolic agents to the uterus and fibroids. Approximately 90% of women who have had UFE have significant or complete relief of their fibroid-related symptoms.

However, due to the high population density of countries like India and China, the Asia-Pacific region is expected to have the fastest growth rate in this market in the near future. Increased patient awareness will also create new growth opportunities. Furthermore, thriving medical tourism industry in countries like India, Thailand, and Singapore, as well as an increase in overall healthcare spending, will help the Asian region's growth. However, growth in this market may be stifled in developed countries due to a lack of proper reimbursement plans.

The market is expected to be driven by the high prevalence of uterine fibroids among women worldwide, rising patient preference for minimally invasive procedures, and the adoption of technologically advanced products.

The report aspects discussed the profile of the top manufacturers of the global Uterine Fibroid Treatment Device market. These aspects include the financial status of major companies, trending advancements, and the entire market scenario. Growth of the report has examined Uterine Fibroid Treatment Device Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.

Who are the Major Players in the Uterine Fibroid Treatment Device Market?

The global Uterine Fibroid Treatment Device includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include Medtronic plc (NYSE: MDT), Stryker Corporation (NYSE: SYK), Boston Scientific Corporation (NYSE: BSX), INSIGHTEC, CooperSurgical Inc., Hologic Inc. (NASDAQ: HOLX), Lumenis, Gynesonics, Chongqing Haifu Medical Technology, Shenzhen PRO HITU Medical, and others.

Industry News and Updates:

July 2020 – Gynesonics, a women's health-focused MedTech company, has developed the Sonata System, a transcervical fibroid ablation system that uses radiofrequency energy to treat symptomatic uterine fibroids. Sonata is a handheld delivery device that combines radiofrequency and ultrasound to detect and then target a single fibroid. With this launch, the company hopes to establish a stronger presence in the endometrial ablation market.

MYFEMBREE®, the first once-daily treatment for heavy menstrual bleeding associated with uterine fibroids, has been approved by the FDA by Myovant Sciences and Pfizer.

May 26, 2021— Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) announced that the FDA has approved MYFEMBREE® (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg), the first once-daily treatment for heavy menstrual bleeding associated with uterine fibroids in premenopausal women, with a treatment duration of up to 24 months.

What are the major Applications, Types, and Regions for the Uterine Fibroid Treatment Device Market?

The market is segmented based on the type, applications, companies, and regions.

By Type, it is segmented into

• Surgical Techniques


• Laparoscopic Techniques


• Ablation Techniques


• Embolization Technique

By Application, it is segmented into

• Invasive Treatment


• Minimally Invasive Treatment


• Non-invasive Treatment

Uterine Fibroid Treatment Device Market Regional Analysis

The market for UFE devices is dominated by the North American region. Europe comes after North America. North America's dominance is due to a rapidly aging population that can afford to spend money on expensive treatments. Furthermore, the presence of major market players has aided North America in gaining a dominant position in the market. Furthermore, rising healthcare awareness among the population and an increase in the number of uterine fibroid patients are driving the growth of this market.

However, due to the high population in countries such as India and China, the Asia-Pacific region is expected to have the fastest growth rate in this market in the near future. Increased patient awareness will also open up new opportunities for growth. Furthermore, a healthy medical tourism sector in countries such as India, Thailand, and Singapore, as well as an increase in overall healthcare spending, will support the Asian region's growth. However, growth in this market may be stifled due to a lack of proper reimbursement plans in developed countries.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Uterine Fibroid Treatment Device Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type, and segment. It focuses extensively on revealing a detailed regional analysis. The Global Uterine Fibroid Treatment Device Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Uterine Fibroid Treatment Device Market report scope?

Scope of the Report covers Uterine Fibroid Treatment Device Market with a detailed analysis of the overall scenario for the market. It also highlights the business participants’ environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background, and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Uterine Fibroid Treatment Device Market analysis report as it has vital details to provide about regional markets and expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how the worldwide market is working through efficient information graphics.

Key Takeaways from this Uterine Fibroid Treatment Device Report

• Evaluate Uterine Fibroid Treatment Device market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at the country level - for product types, end-use applications, and different industries verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges, and hidden opportunities.


• Get in-depth insights on your competitor’s performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis, and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies to your processes.


• Get a quick outlook on the Uterine Fibroid Treatment Device market entropy – M&As, deals, partnerships, and product launches of all key players for the past 5 years.


• Evaluate the import-export statistics, supply-demand, and competitive landscape for more than the top 20 countries globally for the market.

Frequently Asked Questions

What is the study period of this market?

The Uterine Fibroid Treatment Device Market is studied from 2017 - 2027.

What is the growth rate of the Uterine Fibroid Treatment Device Market?

The Uterine Fibroid Treatment Device Market is growing at a CAGR of 9.6% over the next 5 years.

Who are the key players in Uterine Fibroid Treatment Device Market?

Medtronic, Stryker Corporation, Boston Scientific Corporation, INSIGHTEC, CooperSurgical Inc., Hologic, Inc., Lumenis, Gynesonics, Chongqing Haifu Medical Technology, Shenzhen PRO HITU Medical

What regions does this Uterine Fibroid Treatment Device Market report cover?

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

What are the significant types of Uterine Fibroid Treatment Device Market?

Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Technique

What are the major end-use applications of Uterine Fibroid Treatment Device Market?

Invasive Treatment, Minimally Invasive Treatment, Non-invasive Treatment

 

All our reports are custom made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.